Biocon Limited — Others, 17-07-2025: Shareholders meeting

Biocon has announced its 47th Annual General Meeting on August 8, 2025, to be held virtually. The company reported a 5% increase in total income for FY25 to ₹16,469.9 crore, with profit at ₹1,013.3 crore. Generics grew 8% to ₹3,017.5 crore, Biosimilars saw 15% like-to-like growth reaching ₹9,017.4 crore, and Research Services increased 4% to ₹3,642.4 crore. Biocon plans a final dividend of ₹0.50 per share. Key agenda items include approving material related party transactions and increasing investment limits up to ₹8,000 crore, along with re-appointing directors. The company recently raised funds and refinanced $800 million and $320 million of its debt.